Lyra Therapeutics Inc. (LYRA): Price and Financial Metrics
LYRA Price/Volume Stats
| Current price | $5.39 | 52-week high | $6.79 |
| Prev. close | $5.41 | 52-week low | $1.93 |
| Day low | $5.21 | Volume | 387,800 |
| Day high | $5.52 | Avg. volume | 321,121 |
| 50-day MA | $5.50 | Dividend yield | N/A |
| 200-day MA | $4.25 | Market Cap | 322.01M |
LYRA Stock Price Chart Interactive Chart >
Lyra Therapeutics Inc. (LYRA) Company Bio
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer and is headquartered in Watertown, MA.
Latest LYRA News From Around the Web
Below are the latest news stories about LYRA THERAPEUTICS INC that investors may wish to consider to help them evaluate LYRA as an investment opportunity.
4 Drug Stocks Rising More Than 40% in 2023 With Room to GrowNovo Nordisk (NVO), Journey Medical Corporation (DERM), Lyra Therapeutics (LYRA) and Fusion Pharmaceuticals (FUSN) have returned 40% or higher year to date and have room for more growth in 2024. |
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey MedicalAurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical are part of the Zacks Industry Outlook article. |
5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New YearInnovation is expected to continue driving growth in the Medical-Drugs industry. DERM, LYRA, AUPH, ALPN and HARP may prove to be good additions to one's portfolio. |
Lyra Therapeutics Insider Ups Holding By 11% During YearInsiders were net buyers of Lyra Therapeutics, Inc.'s ( NASDAQ:LYRA ) stock during the past year. That is, insiders... |
Executive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More SharesWhilst it may not be a huge deal, we thought it was good to see that the Lyra Therapeutics, Inc. ( NASDAQ:LYRA... |
LYRA Price Returns
| 1-mo | -11.20% |
| 3-mo | 3.65% |
| 6-mo | 50.14% |
| 1-year | 166.83% |
| 3-year | -46.90% |
| 5-year | N/A |
| YTD | 2.86% |
| 2023 | 66.88% |
| 2022 | -27.98% |
| 2021 | -61.75% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...